FDA Inspection 1008978 — Adhexpharma
The FDA completed an inspection of Adhexpharma on February 3, 2017 in Chenove. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 3, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Chenove (France)